This class of drugs works by mimicking a natural hormone in your body called glucagon-like peptide-1
[157] In April 2021, the FDA revoked the emergency use authorization (EUA) that allowed and signaled FDA agreement for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients
Septerna Sector: GPC Septerna R-targeted oral small molecule drug discovery, including GLP-1, GIP, and glucagon receptors HQ: South San Francisco, CA Year Founded: 2019 (under the name GPCR NewCo, Inc.)
Shapely can help patients access self-pay programs for FDA-approved medications, such as Wegovy through NovoCare and Zepbound through Lilly Direct, which may offer discounted pricing for eligible patients
So in summary, BPC 157 shows potential in promoting tissue regeneration, improving blood flow, influencing growth factors, and modulating the inflammatory response
